New risk score could tailor therapy for aggressive myeloma
Disease control
Not yet recruiting
This study aims to personalize treatment for people newly diagnosed with multiple myeloma who have an extra copy of chromosome 1q, a marker of higher risk. Researchers will use a scoring system based on factors like disease stage and lab results to classify patients into low, int…
Sponsor: FengYan Jin • Aim: Disease control
Last updated Jun 26, 2026 17:11 UTC